SIREN : 808343750
HEALTH FACTORY is a French company founded 11 years ago, specialized in the sector Conseil en systèmes et logiciels informatiques. Based in STRASBOURG (67000), this company of category PME shows in 2024 a revenue of 764 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2021 |
|---|---|---|---|
| Revenue | 764 002 € | 1 200 199 € | N/C |
| Net income | 273 253 € | 446 359 € | 237 795 € |
| EBITDA | 333 464 € | 606 356 € | N/C |
| Net margin | 35.8% | 37.2% | N/C |
In 2024, HEALTH FACTORY achieves revenue of 764 k€. Revenue is declining over the period 2023-2024 (CAGR: -36.3%). Significant drop of -36% vs 2023. After deducting consumption (0 €), gross margin stands at 764 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 333 k€, representing 43.6% of revenue. Warning negative scissor effect: despite revenue change (-36%), EBITDA varies by -45%, reducing margin by 6.9 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 273 k€, i.e. 35.8% of revenue. This profit can be retained or distributed to shareholders.
764 002 €
764 002 €
333 464 €
328 607 €
273 253 €
42.5%
The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.2 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 35.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
17.453%
72.171%
35.623%
0.217
27.1%
In 2024, the debt ratio of HEALTH FACTORY (17.45) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of HEALTH FACTORY (72.2%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of HEALTH FACTORY (0.22) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 870.13. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.2x. Coverage is limited: any activity downturn would jeopardize interest payments.
870.129
1.205
In 2024, the liquidity ratio of HEALTH FACTORY (870.13) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of HEALTH FACTORY (1.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 16 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 33 days. Favorable situation: supplier credit is longer than customer credit by 17 days. Overall, WCR represents 36 days of revenue, i.e. 76 k€ to permanently finance.
76 056 €
16 j
33 j
0 j
36 j
Based on 215 transactions of similar company sales (all years), the value of HEALTH FACTORY is estimated at 280 251 € (range 116 077€ - 1 023 506€). With an EBITDA of 333 464€, the sector multiple of 1.0x is applied. The price/revenue ratio is 0.16x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare HEALTH FACTORY with other companies in the same sector:
Voir toutes les statistiques du secteur Conseil en systèmes et logiciels informatiques
The revenue of HEALTH FACTORY in 2024 is 764 k€.
Yes, HEALTH FACTORY generated a net profit of 273 k€ in 2024.
The headquarters of HEALTH FACTORY is located in STRASBOURG (67000), in the department Bas-Rhin.
The tax return of HEALTH FACTORY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
HEALTH FACTORY operates in the sector Conseil en systèmes et logiciels informatiques (NAF code 62.02A). See the 'Sector positioning' section above to compare the company with its competitors.